UBS Group
EQHA

UBS Group’s EQ Health Acquisition Corp. EQHA Stock Holding History

UBS Group’s Portfolio EQHA Stock Details EQHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-900
Closed -$9K – 11522
2022
Q2 		$9K Hold
900
– – ﹤0.01% 8242
2022
Q1 		$9K Hold
900
– – ﹤0.01% 8618
2021
Q4 		$9K Buy
+900
New +$8.77K ﹤0.01% 8978

Other funds holding EQHA

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

UBS Group's EQHA Position: Q3 2022 in Review

UBS Group sold out of EQ Health Acquisition Corp. (EQHA) in Q3 2022, closing a stake of 900 shares — an estimated $9K sold.

UBS Group first reported a position in EQHA in Q4 2021 and held it in 3 quarters. The position peaked at $9K in Q2 2022. 74 funds tracked by Wall St. Rank hold EQHA as of Q3 2022.

  • UBS Group reported no remaining EQ Health Acquisition Corp. position as of Q3 2022 after selling out during the quarter.
  • UBS Group sold 900 EQ Health Acquisition Corp. shares in Q3 2022, an estimated $9K.
  • UBS Group first reported a position in EQ Health Acquisition Corp. in Q4 2021 and held it in 3 quarters.
  • UBS Group's EQ Health Acquisition Corp. position peaked at $9K in Q2 2022.
  • 74 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.